T he article by Aldabbous et al 1 describes neutrophil extracellular traps (NETs) as a novel feature related to the vascular pathology of both pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). NETs were originally identified as a suicide mechanism whereby neutrophil elastase degrades and releases chromatin to trap bacteria. In this article, the authors first describe biomarkers of NETs, that is, elevated circulating levels of neutrophil elastase, myeoloperoxidase, citrullinated histone 3, and DNA in PAH and CTEPH patients. Moreover, they found neutrophils, the primary source of NETs, characterized by elevated peptidylarginine deiminase 4+ in and around occlusive arterial lesions in PAH and CTEPH lungs.
See accompanying article on page 2078
The release of neutrophil elastase in association with NETs is thought to produce collateral tissue damage 2 as reported in other vascular pathologies, notably aneurysm formation 3 and atherosclerosis. 4 Neutrophil elastase, in particular, has been implicated in the pathogenesis of PAH, by releasing of growth factors from the extracellular matrix and activating growth factor receptors, by initiating an elastin peptide mediated inflammatory response and by inducing vascular stiffening. 5 Moreover, elastase inhibitors can prevent and reverse experimental pulmonary hypertension and PA occlusive lesions in human tissue. 6 NETs are generally ingested by scavenging cells, such as MMP12 (matrix metalloproteinase)-producing macrophages, unless the function of those cells is compromised in disease. 7 The collateral damage attributed to NETs in addition to elastase-mediated tissue damage, includes autoantibody formation in response to antigens exposed by NETs, 8 interferon-α production, complement activation, 9 and microthrombi formation. 10 NETs are also induced by immune complexes. 11 Both complement activation and immune complexes are features of PAH as reviewed in Rabinovitch et al. 12 The article by Aldabbous et al 1 elucidates a novel and important collateral damage function of NETs related to disturbed angiogenesis, and cell culture studies reveal the pathway involved. This function of NETs is different from the one related to endothelial cell (EC) apoptosis described in lupus 13 that is also a feature of PAH ECs. [14] [15] [16] Here, the authors provide evidence supporting NET-induced disturbed angiogenesis in PAH, in association with the formation of plexogenic lesions. These occlusive lesions seen in PAH patient lungs are recognized by nests of ECs and endothelial channels in the vascular lumen and throughout the vessel wall. In CTEPH, the angiogenesis induced by NETs is thought to be related to recanalization of thrombi in obstructed blood vessels (Figure) .
To support their hypothesis, the authors remove and characterize intact NETs and show that these structures when in direct contact with PA ECs promote PA EC migration and tube formation in matrigel assays. Most interesting was the profound effect of NETs in enhancing PA EC permeability and platelet adhesion. Although the authors did not investigate the direct impact of NETs on smooth muscle cells, they did note that the conditioned media of NET-activated PA ECs resulted in the proliferation of PA smooth muscle cells.
Release by NETs of myeloperoxidase and reactive oxygen species is required for the NET induction of Toll-like receptor 4-mediated activation of NFκB (nuclear factor kappa B). The impact of NETs on angiogenesis in matrigel tube formation assays is mitigated by DNAse, a myeloperoxidase inhibitor, an NFκB inhibitor or a reactive oxygen species scavenger. Elevated levels of the scaffolding protein CLIC4 (chloride intracellular channel 4) were also implicated in NET-mediated NFκB activation, but the mechanism was not addressed. As a consequence of NFκB activation, the authors show an increase in the leukocyte adhesion molecule ICAM-1 (intracellular adhesion molecule) and heightened transendothelial leukocyte migration. The heightened platelet adhesion is attributed to an increase in vWF (von Willebrand Factor), as it is attenuated by anti-vWF antibodies. Microarray analysis of PA endothelial cells treated with NETs reveals multiple proangiogenesis factors, including Hb-EGF (heparin binding EGF-like growth factor), LAP-TGFβ1 (latency-associated peptide of transforming growth factor beta-1), MMP9, and uPA (urokinase plasminogen activator). The effect of NETactivated PA endothelial cells on smooth muscle cell proliferation is attributed to an increase in endothelin 1 production.
It is interesting that in early lung development, NFκB supports the angiogenesis that is associated with alveolarization and that blockade of NFκB is detrimental. 17 In the context of PAH, and the abnormal milieu of the diseased artery, it is proposed that NFκB activated PA ECs promotes dysregulated angiogenesis and not recovery of lost microvessels associated with alveoli. It would, therefore, be of great interest to understand why there is a context-specific difference in NFκB-mediated angiogenesis. One functional difference between normal and NET-mediated angiogenesis is the heightened permeability of PA endothelial cells, a feature noted in tumor vessels and in autoimmunity. This may reflect impaired investment by pericytes, despite evidence that these cells also accumulate in the plexogenic lesions. 18 Similarly, CLIC4 in PA smooth muscle cells is an important scaffold for BMPR2 signaling that is lost with reduced levels of BMPR2 19 in association with PAH. NET-induced CLIC4 in PA ECs may be permissive to conduct NET-mediated signaling required for the activation of NFκB.
It is of interest that mitochondrial reactive oxygen species and mitochondrial DNA have been previously implicated in the generation of NETs [20] [21] [22] and both are produced in PAH, particularly in response to loss of BMPR2 (bone morphogenetic protein receptor). 16 So while NETs induce PA EC dysfunction, abnormal PA ECs may also induce NETs.
In thromboembolic disease, NETs are presumed to form a scaffold to induce the coagulation cascade. 23 NETs are associated with the vasculopathy of lupus, 24, 25 that is related to premature atherosclerosis and microthrombi. 8 It is possible that the NET-induced angiogenic response presumably related to recanalization of thrombi in CTEPH is a function of production of uPA and MMP9 identified in the PA EC transcriptomic studies presented by the authors.
The role of NETs in EC biology and pathobiology is in a phase of active investigation. The article by Aldabbous et al 1 provides new and important information delineating a signaling pathway that activates NFκB to promote a highly migratory endothelial cell that is also characterized by heightened permeability. Although this is linked to dysregulated angiogenesis associated with plexogenic lesions in PAH and recanalized thrombi in CTEPH, these features may also play a role in tumor angiogenesis.
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Figure.
A diagrammatic representation of findings in this study and also in blue print, additional mechanisms and consequences of NETs important in pulmonary hypertension vascualr pathobiology. CTEPH indicates chronic thromboembolic pulmonary hypertension; mitoDNA, mitochondri; myelo, myeloperoxidase; NETs, neutrophil extracellular traps; PAH, pulmonary arterial hypertension; and ROS, reactive oxygen species.
